About XOStem
XOStem is a Healthcare company based in Irvine (United States) founded in 2018 by John Sanderson. Stem cells and bio-artificial organs are developed for diabetes treatment. XOStem has raised $1.3 million across 4 funding rounds. Its chief executive, as recorded, is John Sanderson. Its focus areas include Life Sciences, Diabetes, Medical Devices and Therapeutic Devices.
Company details
XOStem was founded in 2018 in Irvine, United States, within the biotechnology sector. Stem cell technologies and bio-artificial organs are developed for diabetes treatment, with a focus on Type-1 patients through devices that encase and protect insulin-producing cells. Equipment for cell culturing, isolation, and delivery is provided to enable exosome-based product production. Operations center on advancing regenerative therapies for metabolic disorders.
- Headquarters Irvine, United States
- Founders John Sanderson
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website xostem.com
- Social LinkedIn Facebook
- Total Equity Funding$1.3M (USD)
in 4 rounds
- Latest Funding Round$378K (USD), Seed
Feb 2024
Funding Insights of XOStem
XOStem has successfully raised a total of $1.3M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $378 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.3M
- Total Rounds 4
- Last Round Seed — $378,000
- First Round $302,651
(Jun 2020)
All 4 funding rounds of XOStem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $378,000 | Seed | – | – | – |
| Sep 2023 | $30,000 | Seed | – | – | – |
| Apr 2023 | $587,000 | Seed | – | – | – |
| Jun 2020 | $302,651 | Seed | – | – | – |
People of XOStem
10 people are tracked at XOStem (6 in leadership, 1 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
John Sanderson | Co-Founder & CEO | Leadership |
Brad Eckenweiler | CEO | Leadership |
Brent Coeur-Barron | General Counsel, COO & Secretary | Leadership |
Frank McEnulty | Chief Financial Officer | Leadership |
Chad Friesen | Director | Leadership |
George E Taylor MD | Medical Director | Leadership |
M. Reza Mohammadi | Scientific Advisor | Board & advisors |
Adrian Abalovich | Principal Investigator | Team |
Lijuan Fu | Senior Scientist | Team |
Amanda Berner | Laboratory Technician | Team |
Complete people profiles for XOStem
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of XOStem
3 dated milestones of XOStem across 6 years, from founding to its latest funding, stage changes and deals.
- Founded XOStem is founded.
- Funding First funding round of $303K.
- Funding Latest funding round, Seed, of $378K.
Top companies in Diabetes
3 companies that operate in the same segment as XOStem (Diabetes) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Xostem
Complete news archive for XOStem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about XOStem
XOStem was founded in 2018 and raised its 1st funding round 2 years after it was founded.
XOStem is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
John Sanderson is the CEO of XOStem, as recorded in our data. They have also founded this company.
XOStem is a funded company, having raised a total of $1.3M across 4 funding rounds to date. The company's 1st funding round was a Seed of $302.65K, raised on Jun 2020.
XOStem was founded in 2018 in Irvine, United States, within the biotechnology sector. Stem cell technologies and bio-artificial organs are developed for diabetes treatment, with a focus on Type-1 patients through devices that encase and protect insulin-producing cells. Equipment for cell culturing, isolation, and delivery is provided to enable exosome-based product production. Operations center on advancing regenerative therapies for metabolic disorders.